Loading...

Kamada Ltd.

KMDA•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.28
$0.010(0.12%)
U.S. Market opens in NaNh NaNm

Kamada Ltd. (KMDA) Stock Overview

Explore Kamada Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap477.6M
P/E Ratio23.62
EPS (TTM)$0.35
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$7.45
3 Months$7.55
1 Year Target$9.13

KMDA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kamada Ltd. (KMDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $9.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.62 and a market capitalization of 477.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.12%
5-Day Change
-1.31%
1-Month Change
0.98%
3-Month Change
4.55%
6-Month Change
20.52%
Year-to-Date (YTD) Change
17.28%
1-Year Change
25.08%
3-Year Change
83.59%
5-Year Change
35.52%
All-Time (Max) Change
-21.44%

Contact Information

https://www.kamada.com
972 8 940 6472
2 Holzman Street, Rehovot, NaN, 7670402

Company Facts

420 Employees
IPO DateMay 31, 2013
CountryIL
Actively Trading

Frequently Asked Questions